Quote:Is the purpose of the city of Hope liver study an attempt to get leronlimab established as a front line treatment
I think that's part of it, and it's very exciting. But imo another intriguing part is due to the fact that mets from CRC are often liver tumors. (Can't remember the stat, but I think it's the majority.) They must have seen some liver-tumor shrinkage that would be tremendous if it translates into a trial result.
Leron is of course more than a helpmate for ICI in solid-tumor reduction. What can it do with dual live-CRC cancer? I think that is a central aim of the City of Hope study.